Could gene therapies be used to cure more people with HIV?
Conclusive PrEP study in China paves the way for national provision for gay men
Cash transfers result in reduced AIDS cases, hospitalisations and deaths among Brazil’s poorest
HIV vaccines and immunotherapies “would be further along” if they had the resources of COVID-19, says leading antibody researcher
Young women and pregnant women can effectively use vaginal rings and oral PrEP for HIV prevention
More insulin resistance and worse metabolic profiles in children with HIV, South African study shows
Chemsex on the rise in Thailand and other Asian countries
People with HIV can produce an adequate immune response to SARS-CoV-2
Improved treatment for cryptococcal meningitis, a leading cause of death in people with HIV
Novel dual antibody therapy partially controls virulent HIV infection in monkeys off treatment
Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa
Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women
How can HIV research better align with the realities of transgender and gender-diverse people?
Shorter, less toxic treatment for highly drug-resistant TB cures nine out of ten
Earlier treatment and higher CD4 counts linked to smaller HIV reservoir
PrEP failures in African programmes are rare, but some are happening in people with good adherence
Multiple African countries improved access to HIV treatment during COVID-19 pandemic
Viral suppression in Uganda improved by more viral load tests, done faster
